VeriMomcrataegus pinnatifida fruit extract hamilelikte güvenli mi?
No harmonised CLP reproductive classification for Crataegus pinnatifida fruit extract (no ECHA Annex VI entry). No CIR or SCCS safety assessment flagging reproductive toxicity. PubMed literature on C. pinnatifida reports antioxidant/cardiovascular pharmacology but no consistent evidence of teratogenicity or human reproductive hazard from topical use. Typical topical plant extracts have low but measurable dermal exposure in cosmetics, so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard studies identified), PubChem/CosIng entries (ingredient identity and cosmetic use).
Related ingredients
Frequently asked questions
- crataegus pinnatifida fruit extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classification for Crataegus pinnatifida fruit extract (no ECHA Annex VI entry). No CIR or SCCS safety assessment flagging reproductive toxicity. PubMed literature on C. pinnatifida reports antioxidant/cardiovascular pharmacology but no consistent evidence of teratogenicity or human reproductive hazard from topical use. Typical topical plant extracts have low but measurable dermal exposure in cosmetics, so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard studies identified), PubChem/CosIng entries (ingredient identity and cosmetic use).
- crataegus pinnatifida fruit extract emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific toxicity or transfer in humans for C. pinnatifida fruit extract in the referenced sources. Mechanistic data for placental or breast‑milk transfer are not available. Given low but measurable dermal exposure from cosmetics, exposure scored as low (1). Sources: PubMed (no breastfeeding transfer data), CosIng/PubChem (use and composition information).
- crataegus pinnatifida fruit extract bebek cildi için güvenli mi?
- No infant-specific safety signals or reproductive/dermal toxicity data identified. Mechanistic concerns not identified. Because infant skin has higher absorption (immature barrier and higher surface-area-to-weight), exposure is increased by +1 vs adult (adult e=1 → infant e=2). Sources: general dermal exposure principles, CosIng/PubChem for ingredient use, PubMed (no infant-specific hazard data).
- VeriMom crataegus pinnatifida fruit extract nasıl puanlıyor?
- VeriMom crataegus pinnatifida fruit extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte crataegus pinnatifida fruit extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.